Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,595
Sort by:
2015 Analysis of Cancer Diagnostic Technologies, and Strategic Profiles of Leading Suppliers
US$ 2,800.00
... assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, ...
January 2015
185 pages
2015 European Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 15,760.00
... during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging ... basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
January 2015
820 pages
2015 Global Cancer Diagnostics Market: Toward a New Future for Tumor Markers R&D Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Country Segment Forecasts, Supplier Shares, Innovative Technologies, Competitive Strategies
US$ 27,800.00
... -tailored to your specific information needs and budget. “2015 Global Cancer Diagnostics Market: Toward a New Future for Tumor Markers R&D Oncogenes, ... Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and ...
January 2015
1200 pages
2015 Emerging Cancer Diagnostic Tests and Companies Developing New Technologies
US$ 2,280.00
... Factors, Lymphokines, Immunohistochemical Stains and others. The report presents an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or ...
January 2015
260 pages
Dendritic Cell Cancer Vaccine Market & Clinical Insight
US$ 1,800.00
... Dendritic Cell Cancer Vaccines Dendritic Cell Vaccine Market Overview Market Dynamics (Drivers, Challenges & Future Prospects) Clinical Pipeline Insight by Phase, Indication & Company Dendritic Cell Cancer Vaccine in Clinical Pipeline: 52 Majority of Dendritic Cell Cancer Vaccine ...
January 2015
190 pages
Global Non Small Cell Lung Cancer Market & Pipeline Insight
US$ 2,400.00
... Non Small Cell Lung Cancer Market & Pipeline Insight” Report Highlights: NSCLC Therapy Market Overview Mechanism of NSCLC Therapeutics NSCLC Therapy Market Dynamics: Drivers, Challenges & Future Prospects) NSCLC Drug Pipeline ...
January 2015
750 pages
Global Prostate Cancer Vaccine Clinical Pipeline Insight 2015
US$ 1,500.00
... body to activate the immune cells. They identify these antigens as non-self and begin to search and eliminate cancerous cells from body ... ” Report Highlights: Introduction to Prostate Cancer Vaccine Mechanism of Prostate Cancer Vaccine Global Prostate Cancer Vaccine Clinical Trial Insight by Company, Country ...
January 2015
155 pages
Small Molecule Cancer Drug Clinical Pipeline Insight
US$ 2,400.00
... the treatment of Non-Small Cell Lung Cancer (NSCLC), Colon cancer, Breast and other cancers. Development of small molecule cancer drug generally ... Insight” Report Findings: Role of Small Molecule Drug in Cancer Treatment Mechanism of Small Molecule Cancer Drug Small Molecule Cancer Drugs Market Dynamics ...
January 2015
1650 pages
Competitor Analysis: Cancer Peptides
US$ 500.00
Competitor Analysis: Cancer Peptides The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development pipeline of peptide therapeutics for treatment of cancer. Purchase of the pdf report includes a 6-month online access to the ...
November 2014
99 pages
Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight
US$ 2,400.00
... Non Hodgkin Lymphoma therapeutics. “Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight” Report Highlight: Global Non Hodgkin Lymphoma Market Overview Mechanism of Non Hodgkin Lymphoma Therapeutics Global Non Hodgkin Lymphoma Pipeline by Type, Phase & Company Global Non Hodgkin Lymphoma Pipeline ...
November 2014
573 pages
Global Cancer Monoclonal Antibodies Market & Pipeline Insight
US$ 2,400.00
... Cancer Monoclonal Antibodies Pipeline by Phase, Indication, Company & Country Cancer Monoclonal Antibodies in Pipeline: 605 Majority Cancer Monoclonal Antibodies Preclinical Phase: 258 Marketed Cancer Monoclonal Antibodies: 34 Cancer Monoclonal Antibodies ...
October 2014
1400 pages
Global Cancer Kinase Inhibitors Market & Pipeline Insight
US$ 2,400.00
... Global Cancer Kinase Inhibitors Market & Pipeline Insight” Report Highlight: Classification & Mechanism of Kinase Inhibitors Cancer Kinase Inhibitors Therapy Market Overview Cancer Kinase Inhibitors Therapy Pipeline by Phase, Indication, Company & Country Marketed Cancer Kinase Inhibitors Therapy ...
October 2014
1500 pages
Global Breast Cancer Vaccine Clinical Trial Insight
US$ 1,200.00
... Breast Cancer Vaccine Clinical Trial Insight” Report Highlight: Global Breast Cancer Vaccine Market Overview Global Breast Cancer Vaccine Clinical Pipeline by Company, Phase & Country Mechanism of Breast Cancer Vaccine & Personalized Cancer Vaccines Detailed Clinical Insight on Breast Cancer Vaccine Pipeline ...
October 2014
134 pages
Global Cancer Vaccines Market & Pipeline Analysis
US$ 2,400.00
... Cancer Vaccines Delivery Cancer Vaccines: Mechanism & Innovations Global Cancer Vaccines Clinical Pipeline by Phase, Indication, Company & Country Global Cancer Vaccine Clinical Pipeline: 289 Vaccines Marketed Cancer Vaccines: 12 Vaccines Regulatory Framework for Cancer Vaccines Development & Marketing ...
September 2014
864 pages
Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014
US$ 2,000.00
... trials studies have demonstrated the fact that the potential of peptide based drugs to prevent and eradicate cancer is far effective than conventional ... therapy, both conventional and peptide based cancer therapeutics are used for the treatment. “Global Peptide Cancer Therapeutics Market & Pipeline Insight ...
August 2014
556 pages
Global Cancer Generics Market Outlook 2018
US$ 1,400.00
... growth. According to our latest research report “Global Cancer Generics Market Outlook 2018”, the global oncology market touched a mark of US$ 91 Billion in 2013 ... future incidences, regional analysis and patent expiration status of key cancer drugs. Analysis of key industry trends and drivers crucial to the ...
July 2014
100 pages
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies
US$ 3,900.00
... maintaining front line, product level access and education. In Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies, FirstWord ... marketed and four pipeline products Examination of physicians’ current usage of Medical Affairs teams services Key findings regarding the most and ...
July 2014
54 pages
2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
US$ 27,600.00
... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...
July 2014
1200 pages
2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
US$ 15,760.00
... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...
July 2014
820 pages
